Calendar DBV Technologies

Equities

DBV

FR0010417345

Real-time Euronext Paris 04:57:12 2024-03-28 am EDT 5-day change 1st Jan Change
1.324 EUR -0.53% Intraday chart for DBV Technologies -1.93% -28.39%

Chart calendar DBV Technologies

d0779f67ca13ab494c476b7.FhL5A0TrHAOmh15x89OCYrP_VFuAmOu3aIR3eyhy2n0.T2KJT3eid3GU_20rlpLYNPqQMgy366LBPdYhC00FhRh7RJd0Fd9fdeDTHw~87b26d5b6a033bc57037a395190e3978

Upcoming events on DBV Technologies

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-07-28 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-03-05 Q4 2024 Earnings Release (Projected)

Past events on DBV Technologies

2024-03-07 05:00 pm Q4 2023 Earnings Call
2024-03-07 04:30 pm Q4 2023 Earnings Release
2024-02-24 02:15 pm American Academy of Allergy Asthma and Immunology Meeting
2024-02-24 09:45 am American Academy of Allergy Asthma and Immunology Meeting - Poster No: 379
2023-11-11 08:45 pm American College of Allergy Asthma Immunology Scientific Meeting
2023-11-11 12:40 pm American College of Allergy Asthma & Immunology Scientific Meeting - Abstract ID: LB010
2023-11-11 12:35 pm American College of Allergy Asthma & Immunology Scientific Meeting
2023-11-09 05:00 pm American College of Allergy Asthma & Immunology Scientific Meeting
2023-10-31 05:00 pm Q3 2023 Earnings Call
2023-10-31 04:30 pm Q3 2023 Earnings Release
2023-09-12 04:00 pm H.C. Wainwright Global Investment Conference
2023-07-31 05:00 pm Q2 2023 Earnings Call
2023-07-31 04:25 pm Q2 2023 Earnings Release
2023-06-14 01:00 pm Goldman Sachs Global Healthcare Conference
2023-06-11 06:45 am European Academy of Allergy and Clinical Immunology Congress - Session title: Asthma 3
2023-06-11 06:45 am European Academy of Allergy and Clinical Immunology Congress - Efficacy and Safety of Epicutaneous I
2023-06-10 06:00 am European Academy of Allergy and Clinical Immunology Congress
2023-06-10 06:00 am European Academy of Allergy and Clinical Immunology Congress - Food allergy 2
2023-06-09 06:00 am European Academy of Allergy and Clinical Immunology Congress - Food allergy 1
2023-05-15 09:00 am JMP Securities Life Sciences Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
13,1
14,7
-10.6%
9,42
14,8
-36.11%
5,17
4,32
19.52%
4,53
7,04
-35.67%
14,4
7,78
85.06%

6,53

EBITDA
Million EUR
Released
Forecast
Spread
-149
-155
3.98%
-104
-140
25.29%
-82,3
-87,9
6.4%
-78,7
-67,4
-16.85%
-82,7
-83,0
0.35%

-131

EBIT
Million EUR
Released
Forecast
Spread
-152
-161
5.55%
-113
-150
24.82%
-89,8
-87,2
-2.88%
-90,7
-77,6
-16.98%
-69,9
-87,3
19.9%

-117

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-153
-193
20.58%
-133
-163
18.27%
-144
-97,5
-48.12%
-90,4
-76,2
-18.68%
-66,5
-85,0
21.7%

-114

Net income
Million EUR
Released
Forecast
Spread
-154
-175
12.18%
-133
-166
19.63%
-144
-96,9
-49.04%
-90,5
-75,0
-20.7%
-66,5
-81,6
18.44%

-107

EPS
EUR
Released
Forecast
Spread
-4,15
-3,89
-6.68%
-2,47
-3,88
36.41%
-1,62
-1,75
7.46%
-1,17
-0,87
-34.02%
-0,70
-0,88
20.8%

-0,77

Announcement Date04/03/2011/03/2103/03/2202/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
6,04
7,44
-18.82%
7,60
6,72
13.17%
4,07
7,00
-41.9%
2,65
1,17
126.96%
2,42
1,18
106.06%
1,49
1,15
28.92%
2,13
1,15
84.38%
-1,27
1,01
-225.48%
2,00
1,05
89.69%
2,09
0,79
165.69%
2,27
1,27
79.37%
8,12
1,11
629.94%

1,63


1,63


1,63


1,63

EBIT
Million EUR
Released
Forecast
Spread
-72,4
-83,6
13.38%
-66,6
-77,1
13.6%
-44,7
-81,9
45.41%
-12,7
-28,7
55.69%
-16,0
-23,9
33.28%
-23,2
-16,9
-37%
-18,5
-26,0
29.1%
-35,4
-19,3
-83.92%
-19,2
-23,8
19.59%
-22,7
-24,2
6.23%
-17,2
-26,0
33.82%
-10,9
-30,5
64.18%

-26,0


-28,2


-30,5


-32,0

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-73,2
-83,6
12.34%
-86,5
-78,1
-10.76%
-45,0
-82,3
45.34%
-68,3
-32,3
-111.89%
-15,8
-23,9
33.89%
-22,4
-17,6
-27.34%
-17,7
-29,3
39.47%
-36,7
-21,6
-70.04%
-18,6
-22,4
16.96%
-22,0
-21,9
-0.36%
-15,8
-25,5
37.91%
-10,2
-30,2
66.05%

-19,0


-22,3


-26,3


-31,2

Net income
Million EUR
Released
Forecast
Spread
-73,8
-83,6
11.68%
-86,5
-77,2
-12.03%
-45,0
-82,3
45.35%
-68,3
-27,8
-146.18%
-15,9
-23,9
33.54%
-22,4
-17,5
-27.8%
-17,7
-27,5
35.63%
-36,7
-19,7
-86.32%
-18,6
-21,1
11.83%
-22,0
-21,4
-2.82%
-15,8
-24,6
35.67%
-10,2
-23,8
57.02%

-19,7


-23,0


-26,6


-30,7

EPS
EUR
Released
Forecast
Spread









-0,23
-0,45
47.73%
-0,29
-0,40
29.32%
-0,34
-0,27
-28.08%
-0,18
-0,24
24.41%
-0,42
-0,18
-137.07%
-0,20
-0,27
26.49%
-0,24
-0,28
16.04%
-0,16
-0,27
40.84%
-0,10
-0,31
67%

-0,33


-0,21


-0,16


-0,14

Announcement Date04/03/2031/07/2011/03/2103/03/2202/05/2201/08/2203/11/2202/03/2304/05/2331/07/2331/10/2307/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise